title: Impact of antiretroviral therapy on hepatitis C viraemia in HIV-infected patients.
authors.forename: R
authors.initials: R
authors.lastname: Bravo
authors.forename: V
authors.initials: V
authors.lastname: Soriano
authors.forename: J
authors.initials: J
authors.lastname: García-Samaniego
authors.forename: M
authors.initials: M
authors.lastname: Gómez-Cano
authors.forename: J
authors.initials: J
authors.lastname: González-Lahoz
authors.forename: C
authors.initials: C
authors.lastname: Altisent
authors.forename: I
authors.initials: I
authors.lastname: Ruiz
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006526:Hepatitis C / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage*; D012367:RNA, Viral / Q000097:blood; D014766:Viremia / Q000188:drug therapy* / Q000821:virology; D015215:Zidovudine / Q000008:administration & dosage*
chemical_list: D019380:Anti-HIV Agents; D012367:RNA, Viral; D019259:Lamivudine; D015215:Zidovudine